© 2025 Improve the News Foundation.
All rights reserved.
Version 6.15.0
Prasad had to go because any official who prioritizes political ideology over patient access must be held accountable. His decision to halt a life-saving gene therapy for dying children showed callous disregard for families desperate for treatments. This regulatory overreach worked toward destroying President Trump's pro-patient agenda and Right to Try principles.
Prasad's resignation exposes dangerous political interference in scientific decision-making at the FDA. Although he aligns with right-wing skepticism of vaccines, Prasad was still forced out after making evidence-based safety decisions about a treatment linked to patient deaths. Industry lobbying and activist pressure seem to be overriding legitimate regulatory concerns about drug safety.